Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Cardiac Pacemaker clinical trials

5 of 5 indexed Cardiac Pacemaker trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cardiac Pacemaker: 5 US clinical trials tracked, 5 recruiting.

Cardiac Pacemaker is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Abbott Medical Devices, running 5 of these trials.

Enrollment posture brief

Registry condition cardiac-pacemaker

OPEN 5 | RECR 100% | LATE 0 | EARLY 0 | RANK #3391 | SPON 5

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Cardiac Pacemaker (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Cardiac Pacemaker

Cardiac Pacemaker lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cardiac Pacemaker on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cardiac Pacemaker is recruiting above its size-band peers.

    5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cardiac Pacemaker research.

    Abbott Medical Devices accounts for 5 of 5 trials (100%). 1 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cardiac Pacemaker enrolment sits around 2,100 participants.

    Median target enrolment is 2,100 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Cardiac Pacemaker research leans observational.

    0 interventional and 5 observational studies make up this index (0% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Cardiac Pacemaker records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Aveir DR Leadless Pacemaker System Device
2 trials
Aveir VR Leadless Pacemaker System Device
2 trials
Single-chamber atrial transvenous pacemaker Device
1 trials
Aveir AR Leadless Pacemaker Device
1 trials
Dual Chamber Transvenous Pacemaker Device
1 trials
Single-Chamber Transvenous Pacemaker Device
1 trials

US sites by state

Facility locations filed on Cardiac Pacemaker trials. A trial with sites in several states counts in each.

California 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cardiac Pacemaker page

5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiac Pacemaker condition card totals 5 registered trials; most-linked intervention Aveir DR Leadless Pacemaker System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.